7-(2-(4-(6-fluoro-3-methyl-1,2-benzisox azol5-yl)-1-piperazinyl)ethyl)-2-(1-propynyl)- 7h-pyrazolo-(4,3-e)-(1,2,4)-triazolo-(1,5c)-pyrimidin-5 amine

Details for Australian Patent Application No. 2006294633 (hide)

International Classifications

Event Publications

17 April 2008 PCT application entered the National Phase

PCT publication WO2007/038284 Priority application(s): WO2007/038284

1 March 2012 Application Accepted

Published as AU-B-2006294633

29 March 2012 Corrigenda

28 June 2012 Standard Patent Sealed

23 August 2012 Corrigenda

Applications Accepted - Name Index Under the name Schering Corporation, Application No. 2006294633, under INID (54) correct the title to read 7-[2-[4- (6-fluoro-3-methyl -1,2-benzisoxazol-5-yl) -1-piperazinyl]ethyl] -2- ( 1propynyl) -7h-pyrazolo- [ 4,3-e]-[1,2,4] -triazolo- [1,5-c] -pyrimidin5 amine Specifications Republished The following specifications contained errors when advertised OPI, Accepted or Certified. They have been reissued on the date of this Journal. 2005279221 Nycomed GmbH 2008270170 APLIX

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.